FROM PRESS
to presentations

News

February 7, 2024
REVALESIO ANNOUNCES POSITIVE TOPLINE DATA FROM PHASE 2 RESCUE STUDY OF RNS60 IN PATIENTS WITH ACUTE ISCHEMIC STROKE IN LATE-BREAKING ORAL PRESENTATION AT ISC 2024
February 18, 2022
REVALESIO ANNOUNCES THE DESIGN OF RESCUE, A PHASE 2 TRIAL OF RNS60 IN ACUTE ISCHEMIC STROKE, AND THE PRESENTATION OF PRECLINICAL DATA AT THE INTERNATIONAL STROKE CONFERENCE 2022
DECEMBER 7, 2021
PROMISING CLINICAL DATA ON REVALESIO'S RNS60 PRESENTED AT 32ND INTERNATIONAL SYMPOSIUM ON ALS/MND
All news

Publications

January 2024
RNS60 shows neuroprotective effect in a mouse model of transient focal cerebral ischemia
March 2023
RNS60 induces expression of DJ-1, an important protein in Parkinson's disease, in neuronal cells
October 2022
RNS60 Shows Protective Effects in Cardiac Ischemic Injury
All Publications